© BusinessWire
05.05.2025
OGI
LISTED
NASDAQ
Organigram Global Wins “Exporter of the Year” at the 2025 New Brunswick Export Awards
News Preview
Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (“the Company” or “Organigram”), Canada’s #1 cannabis company by market share, is pleased to announce it has been named Exporter of the Year by Opportunities New Brunswick (“ONB”) as part of the 2025 New Brunswick Export Awards, ONB’s flagship annual event recognizing the successes and innovative ap...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.05.2025
RXRX
LISTED
NASDAQ
Recursion Reports First Quarter 2025 Financial Results and Provides Business Update
News Preview
SALT LAKE CITY, May 05, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX) a leading clinical stage TechBio company decoding biology to radically improve lives, today reported business updates and financial results for its first quarter ended March 31, 2025....
Themefolio
Profiler
Peergroup
© Newsfile
05.05.2025
COPN
LISTED
SIX
Cosmo Highlights Strategic AI and GI Innovation Agenda at Digestive Disease Week(R) 2025
News Preview
Dublin, Ireland--(Newsfile Corp. - May 5, 2025) - Cosmo is attending this year’s Digestive Disease Week® (DDW), held in San Diego, California from May 3-6, where its leadership team is advancing a focused agenda of strategic meetings with key opinion leaders (KOLs), innovators, and potential partners in AI and gastrointestinal...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© Globe Newswire
05.05.2025
KDEV
LISTED
STO
Karolinska Development’s portfolio company Umecrine Cognition receives grant from The Michael J. Fox Foundation
News Preview
STOCKHOLM, SWEDEN – May 5, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Umecrine Cognition has been awarded a research grant by The Michael J. Fox Foundation (MJFF) amounting to USD 420,000. The grant will finance preclinical studies to evaluate the potential treatment effect of golexanolone in...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
05.05.2025
SN
LISTED
LSE
Smith+Nephew to showcase its CORI™ Surgical System at surgical clinics across Germany, Austria and Switzerland
News Preview
“CORI on Tour” will highlight the latest advancements in robotics-assisted surgery for hip and knee joint replacement...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.05.2025
RXRX
LISTED
NASDAQ
Preliminary Phase 1b/2 Data for REC-4881 in Familial Adenomatous Polyposis (FAP) Demonstrates Reduced Polyp Burden
News Preview
SALT LAKE CITY, May 04, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a clinical-stage TechBio company decoding biology to radically improve lives, today announced preliminary safety and efficacy results from its ongoing Phase 1b/2 TUPELO trial of REC-4881, an investigational, allosteric MEK1/2 inhibitor in development for Familial Adenomato...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.05.2025
IBAB
LISTED
EURONEXT
IBA launches QUASAR® GRID3D Advantage Image Distortion Analysis System
News Preview
New standard in the Quality Assurance of image distortion for MR guided radiation therapy and MR simulation in planning...
Themefolio
Profiler
Peergroup
© PR Newswire
03.05.2025
RAY B
LISTED
STO
RaySearch Laboratories and Vision RT present innovations in surface guided treatment planning at ESTRO
News Preview
STOCKHOLM, May 3, 2025 /PRNewswire/ -- At this week's ESTRO conference in Vienna, RaySearch Laboratories AB (publ) and Vision RT proudly announces the next step in their collaboration: the full integration of MapRT with RayStation®* treatment planning system. This integration enables full access to the MapRT clearance map in RayStation to guide t...
Themefolio
Profiler
Peergroup
© Globe Newswire
02.05.2025
IBAB
LISTED
EURONEXT
IBA launches myQA Blue Phantom³ for radiation therapy quality assurance
News Preview
Fastest automatic levelling offering on the market Seamless integration with all linear accelerators...
Themefolio
Profiler
Peergroup
© PR Newswire
02.05.2025
RAY B
LISTED
STO
The Royal Marsden first center in the world to treat a patient using the new adaptive replanning module in RayStation for online adaptive radiotherapy treatment
News Preview
STOCKHOLM, May 2, 2025 /PRNewswire/ -- RaySearch Laboratories AB (publ) is proud to announce that The Royal Marsden NHS Foundation Trust in the UK has treated its first patient using a new and groundbreaking workflow, enabled by the new adaptive replanning module, released in the latest version of RayStation®*. The treatment was carried out with...
Themefolio
Profiler
Peergroup
© PR Newswire
02.05.2025
RAY B
LISTED
STO
RaySearch to showcase its latest innovations in RayStation, RayCare, and RayIntelligence at ESTRO 2025
News Preview
STOCKHOLM, May 2, 2025 /PRNewswire/ -- RaySearch Laboratories AB (publ) is proud to announce our participation at ESTRO in Vienna, Austria, May 3-5, where we will present groundbreaking innovations under our new global campaign Coding Energy to End Cancer. Attendees will be able to book demonstrations of the treatment planning system RayStation®*...
Themefolio
Profiler
Peergroup
© Globe Newswire
02.05.2025
ORNBV
LISTED
HEL
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
News Preview
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS2 May 2025 at 15.15 EEST ...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© BusinessWire
02.05.2025
OGI
LISTED
NASDAQ
Organigram to Report Second Quarter Fiscal 2025 Results on May 12, 2025
News Preview
Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 cannabis company by market share, announced today it will report earnings results for its second quarter fiscal 2025 ended March 31, 2025, on Monday, May 12, 2025, prior to market open.
The Company will host a conference call to discuss its results with...
Themefolio
Profiler
Peergroup
© BusinessWire
02.05.2025
AMRX
LISTED
NASDAQ
Amneal Reports First Quarter 2025 Financial Results
News Preview
Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) today announced its results for the first quarter ended March 31, 2025.
“Amneal delivered another strong quarter to start 2025, with broad-based growth across all three segments driven by our team’s outstanding execution. We are very pleased with the commercial uptake of CREX...
Themefolio
Profiler
Peergroup
© EQS Newswire
02.05.2025
SRT3
LISTED
XETR
Sartorius Supervisory Board extends appointment of board member Alexandra Gatzemeyer
News Preview
At today’s meeting, the Supervisory Board of Sartorius AG resolved to extend the appointment of Dr. Alexandra Gatzemeyer as a member of the Executive Board by a five-year period to April 30, 2031. Gatzemeyer, who holds a Ph.D. in chemistry and pharmacology, has been with Sartorius since 2004 and was appointed to the Executive Board in March 2023. ......
Themefolio
Profiler
Peergroup
© EQS Newswire
02.05.2025
SRT3
LISTED
XETR
Sartorius-Aufsichtsrat verlängert Bestellung von Vorstandsmitglied Alexandra Gatzemeyer
News Preview
Der Aufsichtsrat der Sartorius AG hat in seiner heutigen Sitzung beschlossen, die Bestellung von Dr. Alexandra Gatzemeyer als Mitglied des Vorstands um fünf Jahre bis zum 30. April 2031 zu verlängern. Die promovierte Chemikerin und Pharmakologin ist seit 2004 bei Sartorius tätig und wurde im März 2023 in den Vorstand berufen. Als Vorstandsmitglied......
Themefolio
Profiler
Peergroup
© PR Newswire
02.05.2025
RAY B
LISTED
STO
RaySearch releases RayStation v2025
News Preview
STOCKHOLM, May 2, 2025 /PRNewswire/ -- RaySearch Laboratories AB (publ) announces the launch of RayStation®* v2025, the latest version of the company's innovative treatment planning system. The new version comes with fast automated treatment planning using machine learning** and using the ECHO algorithm, as well as extended support for planning o...
Themefolio
Profiler
Peergroup
© Globe Newswire
02.05.2025
ORNBV
LISTED
HEL
Orion Corporation: Managers’ transactions – Karen Lykke Sørensen
News Preview
ORION CORPORATION MANAGERS’ TRANSACTIONS 2 MAY 2025 at 11.45 EEST ...
Themefolio
Profiler
Peergroup
© Globe Newswire
02.05.2025
ORNBV
LISTED
HEL
Orion Corporation: Managers’ transactions – Eija Ronkainen
News Preview
ORION CORPORATION MANAGERS’ TRANSACTIONS 2 MAY 2025 at 11.45 EEST ...
Themefolio
Profiler
Peergroup
© Globe Newswire
02.05.2025
ORNBV
LISTED
HEL
Orion Corporation: Managers’ transactions – Ari Lehtoranta
News Preview
ORION CORPORATION MANAGERS’ TRANSACTIONS 2 MAY 2025 at 11.45 EEST ...
Themefolio
Profiler
Peergroup
© Globe Newswire
02.05.2025
ORNBV
LISTED
HEL
Orion Corporation: Managers’ transactions – Hilpi Rautelin
News Preview
ORION CORPORATION MANAGERS’ TRANSACTIONS 2 MAY 2025 at 11.45 EEST ...
Themefolio
Profiler
Peergroup
© Globe Newswire
02.05.2025
ORNBV
LISTED
HEL
Orion Corporation: Managers’ transactions – Maziar Mike Doustdar
News Preview
ORION CORPORATION MANAGERS’ TRANSACTIONS 2 MAY 2025 at 11.45 EEST ...
Themefolio
Profiler
Peergroup
© Newsfile
02.05.2025
COPN
LISTED
SIX
Cosmo Announces EU MDR Certification for Endovision's Cerebro, expanding its real-time AI ecosystem
News Preview
Dublin, Ireland--(Newsfile Corp. - May 2, 2025) - Cosmo is excited to announce that Endovision Limited, a leading innovator in endoscopic imaging solutions, has received EU MDR certification[1] for Cerebro, a Real-Time AI-powered guide for complete Esophagogastroduodenoscopy (EGD) procedures. As one of the first Computer-Assisted Qu...
Themefolio
Profiler
Peergroup
© Globe Newswire
02.05.2025
GMAB
LISTED
CPH
Genmab to Submit Supplemental Biologics License Application (sBLA) to U.S. Food and Drug Administration for Epcoritamab Plus Rituximab and Lenalidomide (R2) in Patients with Relapsed/Refractory Follicular Lymphoma (FL)
News Preview
Company Announcement...
Themefolio
Profiler
Peergroup
© PR Newswire
01.05.2025
INDV
LISTED
NASDAQ
New Study Highlights Monthly SUBLOCADE® as a Potential Treatment Option for Opioid Use Disorder During and After Pregnancy
News Preview
SUBLOCADE use during pregnancy showed no increased risk of birth defects, miscarriage, or maternal complications compared to general population rates
RICHMOND, Va., May 1, 2025 /PRNewswire/ -- Indivior PLC (Nasdaq/LSE: INDV) today announced the publication of a study "Monthly Buprenorphine Depot Injection (SUBLOCADE) for Opioid Use Disorder Durin...
Themefolio
Profiler
Peergroup
© PR Newswire
01.05.2025
CRW
LISTED
AIMX
340B Without Compromise: The Craneware Group® Delivers Trusted Innovation
News Preview
DEERFIELD BEACH, Fla., May 1, 2025 /PRNewswire/ -- The Craneware Group, a leader in healthcare financial performance solutions, reaffirms its commitment to America's safety net hospitals by delivering independent, intelligent, and invested support for 340B Covered Entities. Built on a foundation of trust and transparency, The Craneware Group empo...
Themefolio
Profiler
Peergroup
© Globe Newswire
01.05.2025
ZEAL
LISTED
CPH
Zealand Pharma conference call on May 8 at 2pm CET (8am ET) to present first quarter 2025 financial results
News Preview
Press Release – No. 7 / 2025...
Themefolio
Profiler
Peergroup
© BusinessWire
01.05.2025
TEM
LISTED
NASDAQ
Tempus TIME Network Expands Support of Phase I Clinical Trials To Accelerate Activation and Enrollment
News Preview
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, is leveraging its TIME Network to expand its support in phase I clinical trials. Since its inception in 2019, TIME has supported the rapid patient identification and site activation of clinical trials, bringing cutting-edg...
Themefolio
Profiler
Peergroup
© BusinessWire
01.05.2025
HELP
LISTED
NASDAQ
Cybin to Participate at the 28th Annual Milken Institute Global Conference
News Preview
Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options, today announced that Doug Drysdale, Cybin’s Chief Executive Officer, will be speaking at the 28th Annual...
Themefolio
Profiler
Peergroup
© Globe Newswire
01.05.2025
MDGL
LISTED
NASDAQ
Madrigal Pharmaceuticals Reports First-Quarter 2025 Financial Results and Provides Corporate Updates
News Preview
CONSHOHOCKEN, Pa., May 01, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today reports first-quarter 2025 financial results and provides corporate updates....
Themefolio
Profiler
Peergroup
© Globe Newswire
01.05.2025
COLO B
LISTED
CPH
Coloplast A/S Revised guidance for FY 2024/25
News Preview
Coloplast revises financial guidance for FY 2024/25 and pre-announces H1 2024/25 key financial figures...
Themefolio
Profiler
Peergroup
© BusinessWire
30.04.2025
ICLR
LISTED
NASDAQ
ICON Reports First Quarter 2025 Results
News Preview
ICON plc (NASDAQ: ICLR), a world-leading clinical research organization powered by healthcare intelligence, today reported its financial results for the first quarter ended March 31, 2025.
CEO, Dr. Steve Cutler commented, “ICON’s performance in quarter one was impacted by the volatility and cautiousness that continues to be present in the broader...
Themefolio
Profiler
Peergroup
© BusinessWire
30.04.2025
TFX
LISTED
NYSE
TFX Investors Have Opportunity to Join Teleflex Incorporated Fraud Investigation with the Schall Law Firm
News Preview
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Teleflex Incorporated (“Teleflex” or “the Company”) (NYSE: TFX) for violations of the securities laws.
The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to d...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.04.2025
GN
LISTED
CPH
Interim Report Q1 2025: Growth challenged by market uncertainty – proactive cost mitigation initiated to support long-term margins
News Preview
Highlights...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.04.2025
OSE
LISTED
EURONEXT
Mise à disposition du Document d’Enregistrement Universel incluant le Rapport Financier 2024
News Preview
Mise à disposition du Document d’Enregistrement Universel incluant le Rapport Financier 2024...
Themefolio
Profiler
Peergroup
© PR Newswire
30.04.2025
AFX
LISTED
XETR
ZEISS unveils AI-powered Research Data Platform; collaboration with Boehringer Ingelheim champions the future of personalized eye care
News Preview
Showcasing the future of ophthalmic research at ARVO 2025:
ZEISS Research Data Platform launch - a cloud-based, AI-driven technology solution designed to accelerate discoveries, integrating research and clinical data, and simplifying research workflows.ZEISS's collaboration with Boehringer Ingelheim - championing data-driven, personalized care th...
Themefolio
Profiler
Peergroup
© PR Newswire
30.04.2025
VITR
LISTED
STO
Report from Annual General Meeting of Vitrolife AB (publ)
News Preview
GOTHENBURG, Sweden, April 30, 2025 /PRNewswire/ -- At the Annual General Meeting of Vitrolife AB today, the following, amongst other things, was decided:
Resolution in accordance with the Board's proposed dividend of SEK 1.10 per share for the financial year 2024. 2 May, 2025 was adopted as the record day.Re-election of Board members Henrik Blom...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.04.2025
KDEV
LISTED
STO
Interim Report - January-March 2025
News Preview
STOCKHOLM – 30 April 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today publishes its Interim Report January-March 2025. The full report is available on the Company's website....
Themefolio
Profiler
Peergroup
© BusinessWire
30.04.2025
TFX
LISTED
NYSE
Rosen Law Firm Encourages Teleflex Incorporated Investors to Inquire About Securities Class Action Investigation – TFX
News Preview
Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Teleflex Incorporated (NYSE: TFX) resulting from allegations that Teleflex may have issued materially misleading business information to the investing public.
So What: If you purchased Teleflex securities...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.04.2025
GNFT
LISTED
EURONEXT
GENFIT Announces Publication of the 2024 Universal Registration Document and the 2024 Annual Report on Form 20-F
News Preview
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), April 29, 2025 - GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announces the filing of its 2024 Universal Registration Document with the Autorité des marc...
Themefolio
Profiler
Peergroup
© ActuNews
29.04.2025
ALTHX
LISTED
EURONEXT
THERANEXUS PUBLISHES ITS 2024 FULL-YEAR RESULTS, PRESENTS ITS PROGRESS REPORT AND CLOSES ITS EQUITY LINE
News Preview
Lyon, France – 29 April 2025 – 7pm CET – Theranexus, a biopharmaceutical company innovating in the treatment of rare neurological diseases, today publishes its results for the year ending 31 December 2024 and its cash position as of 31 March 2024, and presents its progress report.
“Our financial horizon now extends to June...
Themefolio
Profiler
Peergroup
© ActuNews
29.04.2025
ALTHX
LISTED
EURONEXT
THERANEXUS PUBLIE SES RÉSULTATS ANNUELS 2024, FAIT LE POINT SUR SES ACTIVITÉS ET CLÔTURE SA LIGNE DE FINANCEMENT
News Preview
THERANEXUS PUBLIE SES RÉSULTATS ANNUELS 2024,
FAIT LE POINT SUR SES ACTIVITÉS ET CLÔTURE SA LIGNE DE FINANCEMENT
Lyon, France – 29 avril 2025 – 19h00 CET – Theranexus, société biopharmaceutique innovante dans le traitement des maladies neurologiques rares, publie aujourd'hui ses résulta...
Themefolio
Profiler
Peergroup
© PR Newswire
29.04.2025
VITR
LISTED
STO
Report from Annual General Meeting of Vitrolife AB (publ)
News Preview
GOTHENBURG, Sweden, April 29, 2025 /PRNewswire/ -- At the Annual General Meeting of Vitrolife AB today, the following, amongst other things, was decided:
Resolution in accordance with the Board's proposed dividend of SEK 1.10 per share for the financial year 2024. 2 May, 2025 was adopted as the record day.Re-election of Board members Henrik Blom...
Themefolio
Profiler
Peergroup
© Newsfile
29.04.2025
COPN
LISTED
SIX
Cosmo Pharmaceuticals Confirms Financial Guidance Following CHMP Opinion on Winlevi(R)
News Preview
Dublin, Ireland--(Newsfile Corp. - April 29, 2025) - Following the recent CHMP opinion regarding the marketing authorization application for Winlevi® (clascoterone cream 1%) in Europe, Cosmo Pharmaceuticals N.V. (SIX: COPN) confirms that its financial guidance for 2025 remains unchanged. While the company is disappointe...
Themefolio
Profiler
Peergroup
© BusinessWire
29.04.2025
TEM
LISTED
NASDAQ
Tempus Publishes Study Validating the Benefits of xF+, its Comprehensive Liquid Biopsy Assay for Therapy Selection
News Preview
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced publication of its study, “Analytical Validation of NGS-based Comprehensive Liquid Biopsy Assay for Therapy” in the Journal of Molecular Diagnostics. Data from this study supports the utility of xF+ as a no...
Themefolio
Profiler
Peergroup
© BusinessWire
29.04.2025
OGI
LISTED
NASDAQ
Organigram Global Congratulates Mark Carney on Election Win
News Preview
Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada’s #1 cannabis company by market share, congratulates Prime Minister Mark Carney on the results of the 2025 federal election and urges policymakers to act swiftly in recognizing and elevating the cannabis sector as a critical pillar in Canada’s economic growth...
Themefolio
Profiler
Peergroup
© EQS Newswire
29.04.2025
EVT
LISTED
XETR
Bekanntgabe der Ergebnisse für das erste Quartal 2025 am 6. Mai 2025
News Preview
Hamburg, 29. April 2025:
Die Evotec SE (Frankfurter Wertpapierbörse: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) veröffentlicht am Dienstag, 6. Mai 2025, ihre Zwischenmitteilung über das erste Quartal 2025.
In einer Telefonkonferenz in englischer Sprache werden die Ergebnisse und Schwerpunkte aus dem Berichtszeitraum näher erläutert. Außer......
Themefolio
Profiler
Peergroup
© EQS Newswire
29.04.2025
EVT
LISTED
XETR
Evotec SE to announce results for the first quarter 2025 on 6 May 2025
News Preview
Hamburg, Germany, 29 April 2025:
Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) will announce its interim statement for the first quarter of 2025 on Tuesday, 6 May 2025.
The Company is going to hold a conference call to discuss the results as well as provide an update on its performance. The conference call......
Themefolio
Profiler
Peergroup
© PR Newswire
29.04.2025
SECT_B
LISTED
STO
One of the world's most prestigious cancer centers adopts Sectra for integrated diagnostics and improved patient care
News Preview
LINKÖPING, Sweden and SHELTON, Conn., April 29, 2025 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) will provide its enterprise imaging solution as a cloud service, Sectra One Cloud, to a US cancer center under a new agreement. The fully managed service aims to improve physician collaboration throu...
Themefolio
Profiler
Peergroup
© PR Newswire
29.04.2025
SOBI
LISTED
STO
Sobi publishes Q1 2025 report: Portfolio continues to deliver
News Preview
STOCKHOLM, April 29, 2025 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the first quarter 2025
First Quarter 2025
Total revenue increased 3 per cent, 3 per cent at constant exchange rates, (CER)1, to SEK 6,465 M (6,256)Haematology revenue increased 13 per cent at CER to SEK 4,632 M (4,075), mainly driv...
Themefolio
Profiler
Peergroup
© PR Newswire
29.04.2025
SOBI
LISTED
STO
Sobi publishes Q1 2025 report: Portfolio continues to deliver
News Preview
STOCKHOLM, April 29, 2025 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the first quarter 2025
First Quarter 2025
Total revenue increased 3 per cent, 3 per cent at constant exchange rates, (CER)1, to SEK 6,465 M (6,256)Haematology revenue increased 13 per cent at CER to SEK 4,632 M (4,075), mainly driv...
Themefolio
Profiler
Peergroup
© Newsfile
29.04.2025
COPN
LISTED
SIX
Cosmo Receives Negative CHMP Opinion on Winlevi(R) (clascoterone Cream 1%) in Europe and Will Appeal the Decision
News Preview
Ad hoc announcement pursuant to Art. 53 LR Dublin, Ireland--(Newsfile Corp. - April 29, 2025) - Cosmo Pharmaceuticals N.V. (SIX: COPN) announces that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a negative opinion on the marketing authorization application (MAA) for...
Themefolio
Profiler
Peergroup
© Newsfile
29.04.2025
COPN
LISTED
SIX
Cosmo Publishes Agenda of AGM 2025
News Preview
Dublin, Ireland--(Newsfile Corp. - April 29, 2025) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo” or the “Company”) today announced the convening of its Annual General Meeting 2025 to be held on Friday 30 May 2025, at 12:00 CEST, at Strawinskyhuis, Prinses Amaliaplein 3, 1077 XS Amsterdam, the Nether...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
29.04.2025
EVT
LISTED
XETR
Evotec SE to Announce Results for the First Quarter 2025 on 6 May 2025
News Preview
HAMBURG, DE / ACCESS Newswire / April 29, 2025 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) will announce its interim statement for the first quarter of 2025 on Tuesday, 6 May 2025.The Company is going to hold a conference call to discuss the results as well as provide an update on its performance. The c...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.04.2025
GNFT
LISTED
EURONEXT
GENFIT: positive late-breaking Phase 2 data for elafibranor in Primary Sclerosing Cholangitis (PSC) to be presented by Ipsen at EASL Congress 2025
News Preview
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), April 28, 2025 - GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced that Ipsen will be presenting data from its late-breaking abstract on elafibranor...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.04.2025
REC
LISTED
EURONEXT
RECORDATI: 2025-2027 THREE-YEAR PLAN APPROVED FY 2027 TARGETS OF REVENUE BETWEEN € 3,000 AND € 3,200 MILLION; EBITDA(1) BETWEEN € 1,140 AND € 1,225 MILLION; ADJUSTED NET INCOME(2) BETWEEN € 770 AND € 820 MILLION
News Preview
RECORDATI: 2025-2027 THREE-YEAR PLAN APPROVED FY 2027 TARGETS OF REVENUE BETWEEN € 3,000 AND € 3,200 MILLION; EBITDA(1) BETWEEN € 1,140 AND € 1,225 MILLION; ADJUSTED NET INCOME(2) BETWEEN € 770 AND € 820 MILLION...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.04.2025
IBAB
LISTED
EURONEXT
IBA – ACQUISITION OF OWN SHARES
News Preview
Immediate Release – April 28th, 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.04.2025
IBAB
LISTED
EURONEXT
IBA – TRANSPARENCY NOTIFICATION
News Preview
(Article 14, paragraph 1 of the law of 2 May 2007 on the disclosure of major holdings)...
Themefolio
Profiler
Peergroup
© PR Newswire
28.04.2025
ATNM
LISTED
XASE
Actinium Presents Data Showing ATNM-400 is More Efficacious than Pluvicto and is Highly Efficacious after Pluvicto Resistance in Prostate Cancer Tumor Models at the American Association for Cancer Research Annual Meeting
News Preview
- Results highlight ATNM-400's potential as a transformative therapeutic option for prostate cancer patients with unmet clinical needs as expression of the target receptor for ATNM-400 persists following Pluvicto therapy and ATNM-400 demonstrates sustained tumor control after Pluvicto stops working
- ATNM-400 showed greater tumor growth inhibit...
Themefolio
Profiler
Peergroup
© BusinessWire
28.04.2025
TEM
LISTED
NASDAQ
Tempus Introduces Loop, an AI-Powered Target Discovery and Validation Platform
News Preview
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced Tempus Loop, a new oncology-focused platform for target discovery and validation. Loop is Tempus’ proprietary approach to novel target identification that integrates real-world patient data (RWD) with human...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
